Skip to content
value.today

NextHealth Technologies, Inc.

🇺🇸 Denver, Colorado, USATechnologyFounded 2016
Total raised
$27 M
3 rounds on record
Latest round
$17 M
Feb 2019
First round on record
Aug 2016
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of NextHealth Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2019$17 MNo. 3$10 to $50 million

NextHealth Technologies, Inc.: Raise no. 3, Feb 2019

Investors in this round

9 investors had bought by the notice of Mar 5, 2019: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $18 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anne Marie Aponte · Executive Officer
  • Eric Grossman · Executive Officer, Director, Promoter
  • Jeff Maxwell · Executive Officer
  • Melissa O'Connor · Executive Officer
  • Ron Villarreal · Executive Officer
  • Sonu Kansal · Executive Officer
  • Casper de Clercq · Director
  • David Klein · Director
  • Earl Devanny III · Director
  • Peter Everett · Director
  • Ryan Engle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Offer and Sale of Series B Preferred Stock and Conversion of Convertible Promissory Notes into Series B Preferred Stock”

Signed by Ron Villarreal, Secretary. Source: SEC Form D, newest notice filed Mar 5, 2019. Read the notice at the SEC.

equitySEC
Jul 2018$1 MNo. 2Under $2 million

NextHealth Technologies, Inc.: Raise no. 2, Jul 2018

Investors in this round

7 investors had bought by the notice of Dec 14, 2018: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric Grossman · Executive Officer, Director, Promoter · President, Chief Executive Officer, and Treasurer
  • Casper de Clercq · Director
  • David Klein · Director
  • Earl Devanny III · Director
  • Peter Everett · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Offer and Sale of Convertible Promissory Notes (and the capital stock issuable thereunder)”

Signed by Eric Grossman, President. Source: SEC Form D, newest notice filed Dec 14, 2018. Read the notice at the SEC.

equity, debtSEC
Aug 2016$8 MNo. 1$2 to $10 million

NextHealth Technologies, Inc.: Raise no. 1, Aug 2016

Investors in this round

11 investors had bought by the notice of Aug 23, 2016: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric Grossman · Executive Officer, Director, Promoter · President, Chief Executive Officer, and Treasurer
  • Marla Dugger · Executive Officer · General Counsel and Secretary
  • Casper de Clercq · Director
  • Daniel Spirek · Director
  • Peter Everett · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Offer and Sale of Series A Preferred Stock and Conversion of Convertible Debt”

Signed by Eric Grossman, President. Source: SEC Form D, newest notice filed Aug 23, 2016. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • NextHealth Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2019).

    SEC Form D · Mar 2019

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Mar 2019

That is all the official record says: NextHealth Technologies, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of NextHealth Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by NextHealth Technologies, Inc.
NameRoleNamed in
Anne Marie AponteExecutive officerMar 2019
Eric GrossmanExecutive officerMar 2019
Jeff MaxwellExecutive officerMar 2019
Melissa O'ConnorExecutive officerMar 2019
Ron VillarrealExecutive officerMar 2019
Sonu KansalExecutive officerMar 2019
Marla DuggerGeneral Counsel and SecretaryAug 2016
Casper de ClercqDirectorMar 2019
David KleinDirectorMar 2019
Earl Devanny IIIDirectorMar 2019
Eric GrossmanDirectorMar 2019
Peter EverettDirectorMar 2019
Ryan EngleDirectorMar 2019
Daniel SpirekDirectorAug 2016
Eric GrossmanPromoterMar 2019